JP2009523124A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009523124A5 JP2009523124A5 JP2008546224A JP2008546224A JP2009523124A5 JP 2009523124 A5 JP2009523124 A5 JP 2009523124A5 JP 2008546224 A JP2008546224 A JP 2008546224A JP 2008546224 A JP2008546224 A JP 2008546224A JP 2009523124 A5 JP2009523124 A5 JP 2009523124A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- effective
- research
- treatment
- strong
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000002193 Pain Diseases 0.000 description 5
- 238000011282 treatment Methods 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 208000021722 neuropathic pain Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010038678 Respiratory depression Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005061430A DE102005061430A1 (de) | 2005-12-22 | 2005-12-22 | Substituierte Imidazolin-Derivate |
| PCT/EP2006/012221 WO2007079927A1 (de) | 2005-12-22 | 2006-12-19 | Substituierte imidazolin-derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009523124A JP2009523124A (ja) | 2009-06-18 |
| JP2009523124A5 true JP2009523124A5 (https=) | 2012-12-13 |
Family
ID=37946192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546224A Ceased JP2009523124A (ja) | 2005-12-22 | 2006-12-19 | 置換されたイミダゾリン誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7728028B2 (https=) |
| EP (1) | EP1963278B1 (https=) |
| JP (1) | JP2009523124A (https=) |
| CN (1) | CN101384557A (https=) |
| AT (1) | ATE449075T1 (https=) |
| AU (1) | AU2006334743B2 (https=) |
| CA (1) | CA2633918A1 (https=) |
| CY (1) | CY1110465T1 (https=) |
| DE (2) | DE102005061430A1 (https=) |
| DK (1) | DK1963278T3 (https=) |
| ES (1) | ES2336833T3 (https=) |
| IL (1) | IL192268A0 (https=) |
| PL (1) | PL1963278T3 (https=) |
| PT (1) | PT1963278E (https=) |
| RU (1) | RU2427571C2 (https=) |
| SI (1) | SI1963278T1 (https=) |
| WO (1) | WO2007079927A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009228647B2 (en) | 2008-03-27 | 2013-07-04 | Grunenthal Gmbh | Substituted spirocyclic cyclohexane derivatives |
| JP5529843B2 (ja) | 2008-03-27 | 2014-06-25 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 置換シクロヘキシルジアミン |
| EP2280941B1 (de) | 2008-03-27 | 2015-05-06 | Grünenthal GmbH | (hetero-)aryl-cyclohexan-derivate |
| ES2375543T3 (es) | 2008-03-27 | 2012-03-01 | Grünenthal GmbH | Derivados de espiro(5.5)undecano. |
| ES2464102T3 (es) | 2008-03-27 | 2014-05-30 | Grünenthal GmbH | Derivados de 4-aminociclohexano sustituidos |
| CN102046591B (zh) | 2008-03-27 | 2014-12-03 | 格吕伦塔尔有限公司 | 羟甲基环己胺 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952360A (en) * | 1997-08-28 | 1999-09-14 | Eli Lilly And Company | Method for treating neuropathic pain |
| AU9034798A (en) * | 1997-08-28 | 1999-03-16 | Eli Lilly And Company | Method for treating pain |
| DE10000312A1 (de) * | 2000-01-05 | 2001-07-12 | Gruenenthal Gmbh | Substituierte Aminomethyl-Phenyl-Cyclohexanderivate |
| EP1486490A1 (en) * | 2002-02-28 | 2004-12-15 | Takeda Chemical Industries, Ltd. | Azole compounds |
| US7345078B2 (en) * | 2002-05-31 | 2008-03-18 | The Board Of Trustees Of Michigan State University | NF-κB inhibitors and uses thereof |
| US6878735B2 (en) * | 2002-05-31 | 2005-04-12 | Board Of Trustees Of Michigan State University | Multi-substituted imidazolines and method of use thereof |
| DE102005061429A1 (de) * | 2005-12-22 | 2007-06-28 | Grünenthal GmbH | Substituierte Oxazol-Derivate |
-
2005
- 2005-12-22 DE DE102005061430A patent/DE102005061430A1/de not_active Withdrawn
-
2006
- 2006-12-19 AU AU2006334743A patent/AU2006334743B2/en not_active Ceased
- 2006-12-19 DK DK06841028.1T patent/DK1963278T3/da active
- 2006-12-19 EP EP06841028A patent/EP1963278B1/de not_active Not-in-force
- 2006-12-19 PT PT06841028T patent/PT1963278E/pt unknown
- 2006-12-19 RU RU2008129377/04A patent/RU2427571C2/ru not_active IP Right Cessation
- 2006-12-19 CA CA002633918A patent/CA2633918A1/en not_active Abandoned
- 2006-12-19 CN CNA2006800532577A patent/CN101384557A/zh active Pending
- 2006-12-19 ES ES06841028T patent/ES2336833T3/es active Active
- 2006-12-19 SI SI200630546T patent/SI1963278T1/sl unknown
- 2006-12-19 WO PCT/EP2006/012221 patent/WO2007079927A1/de not_active Ceased
- 2006-12-19 DE DE502006005426T patent/DE502006005426D1/de active Active
- 2006-12-19 PL PL06841028T patent/PL1963278T3/pl unknown
- 2006-12-19 JP JP2008546224A patent/JP2009523124A/ja not_active Ceased
- 2006-12-19 AT AT06841028T patent/ATE449075T1/de active
-
2008
- 2008-06-18 IL IL192268A patent/IL192268A0/en unknown
- 2008-06-20 US US12/143,566 patent/US7728028B2/en not_active Expired - Fee Related
-
2010
- 2010-02-02 CY CY20101100093T patent/CY1110465T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007523178A5 (https=) | ||
| WO2010040112A3 (en) | Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1 | |
| WO2008027449A3 (en) | Methods, compositions and apparatuses to treat wounds with pressures altered from atmospheric | |
| WO2007025286A3 (en) | Therapy procedure for drug delivery for trigeminal pain | |
| WO2007081949A3 (en) | Small-volume oral transmucosal dosage forms | |
| WO2008036682A3 (en) | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates | |
| JP2009506076A5 (https=) | ||
| EP3150204A3 (en) | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | |
| WO2008087186A3 (en) | Peptides for use in the treatment of obesity | |
| WO2007009894A3 (en) | Peptides for use in the treatment of obesity | |
| AR124500A2 (es) | Aumento de la biodisponibilidad de droga en terapia naltrexona | |
| WO2009140416A3 (en) | Treatment for epilepsy | |
| RU2010143864A (ru) | Способы лечения нарушений с применением селективного антагониста nr2b-подтипа nmda рецепторов | |
| WO2004103297A3 (en) | Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis | |
| MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
| EP2283843A3 (en) | Opioids for the treatment of the chronic obstructive pulmonary disease (COPD) | |
| WO2011041632A3 (en) | Combination therapies for the treatment of obesity | |
| WO2008087188A3 (en) | Peptides for use in the treatment of obesity | |
| WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
| WO2006036770A3 (en) | Combination therapy for the treatment of obesity | |
| WO2008045378A3 (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin | |
| WO2008012796A3 (en) | Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation | |
| JP2009523124A5 (https=) | ||
| WO2007143185A3 (en) | Transdermal treatment of tendinopathy using glyceryl trinitrite | |
| WO2006048450A3 (en) | Peptides for use in the treating obesity |